# <tt>cholostyramine</tt>
## Impact of compliance on cholesterol reduction in cholostyramine trial

### Description

This data comes from a clinical trial investigating whether the drug cholostyramine lowered blood cholesterol levels. The men were supposed to take six packets of cholostyramine per day, but many actually took much less.

### Dimensions

* 164 observations
* 2 variables

### Variables

* <tt>Compliance</tt>: Percentage of the intended dose actually taken (as measured by pill counts)
* <tt>Improvement/tt>: Decrease in cholesterol from the beginning to the end of the trial (mg/dL)

### Reference

> Efron B and Feldman D. (1991). Compliance as an Explanatory Variable in Clinical Trials.  <em>Journal of the American Statistical Association</em>, <b>86</b>:9-17.
